{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psychosis%3B+Acute&page=3", "query": { "condition": "Psychosis; Acute", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 65, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psychosis%3B+Acute&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psychosis%3B+Acute&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T11:38:06.149Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02477020", "title": "A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "TAK-063 20 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 164, "start_date": "2015-07-01", "completion_date": "2016-07-27", "has_results": true, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 15, "location_summary": "Springdale, Alaska • Culver City, California • Lemon Grove, California + 12 more", "locations": [ { "city": "Springdale", "state": "Alaska" }, { "city": "Culver City", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Pico Rivera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02477020" }, { "nct_id": "NCT00556140", "title": "The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psychotic Depression" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 16, "start_date": "2003-06", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2012-08-20", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00556140" }, { "nct_id": "NCT00409370", "title": "Trial of Safety Nets In Hospitalized Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Delirium", "Agitated Behavior", "Alcohol Withdrawl", "Acute Confusional State", "Acute Psychosis" ], "interventions": [ { "name": "SOMA safe enclosure", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Griffin Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2003-04", "completion_date": "2005-02", "has_results": false, "last_update_posted_date": "2006-12-08", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 1, "location_summary": "Derby, Connecticut", "locations": [ { "city": "Derby", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00409370" }, { "nct_id": "NCT00061802", "title": "Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "risperidone, quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 225, "start_date": "2003-06", "completion_date": "2004-02", "has_results": false, "last_update_posted_date": "2012-02-07", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 7, "location_summary": "San Diego, California • Hoffman Est, Illinois • Lake Charles, Louisiana + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Hoffman Est", "state": "Illinois" }, { "city": "Lake Charles", "state": "Louisiana" }, { "city": "Jackson", "state": "Mississippi" }, { "city": "Visakhapatnam", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061802" }, { "nct_id": "NCT01104766", "title": "Safety and Efficacy of Cariprazine in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Cariprazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 617, "start_date": "2010-04-23", "completion_date": "2011-12-20", "has_results": true, "last_update_posted_date": "2018-10-29", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Escondido, California + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01104766" }, { "nct_id": "NCT00549718", "title": "Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 489, "start_date": "2007-10", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2014-06-11", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Cerritos, California • Costa Mesa, California + 18 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00549718" }, { "nct_id": "NCT00259870", "title": "SB-773812 Administered In Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "SB-773812", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 338, "start_date": "2005-09", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2017-03-23", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Cerritos, California • Garden Grove, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00259870" }, { "nct_id": "NCT07734493", "title": "A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LTX-001 once daily", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "LTX-001 twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Leal Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 90, "start_date": "2026-08-03", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • Los Alamitos, California • DeLand, Florida + 6 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Alamitos", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07734493" }, { "nct_id": "NCT00905307", "title": "Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "OPC-34712", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 459, "start_date": "2009-07", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2015-10-20", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 16, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 12 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00905307" }, { "nct_id": "NCT00570063", "title": "Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "PF-02545920", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 35, "start_date": "2007-11", "completion_date": "2008-02-18", "has_results": true, "last_update_posted_date": "2017-12-20", "last_synced_at": "2026-11-15T11:38:06.149Z", "location_count": 10, "location_summary": "Glendale, California • Lemon Grove, California • Paramount, California + 4 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00570063" } ] }